
Do Polygenic Risk Scores Actually Change Clinical Outcomes?
Dr. Dereck Mush, MD, MBAResearch
The leading global conference for health economics, outcomes research, and real world evidence generation in healthcare.
ISPOR is the key scientific event for evaluating the value and efficacy of new pharmaceuticals, diagnostics, and digital health therapeutics. The conference brings together researchers, payers, and health technology assessment bodies to discuss methods of outcomes evaluation. It highlights advances in real world evidence, patient reported outcomes, and cost effectiveness models. For digital health and life science investors, the methodologies debated here dictate how health products are priced and reimbursed globally.
Attendees include health economists, real world evidence researchers, pharmaceutical access directors, and public health policy analysts.
ISPOR was founded in 1995 to promote health economics and outcomes research excellence globally. It has grown from a specialized academic gathering into a major global congress shaping healthcare pricing and value determination.
Running this event, or spotted something out of date?

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring